Documents to download

On 4 July 2019, the House of Lords is due to debate a motion tabled by Lord Brooke of Alverthorpe (Labour) that “this House takes note of the case for protecting the National Health Service in future trade deals entered into by the United Kingdom”.

One of the Government’s main Brexit objectives has been to enable the UK to pursue an independent trade policy once it has left the EU. The Government’s policy is to replicate as far as possible the current trading arrangements with countries that have a trade agreement with the EU. It also wants to negotiate new trade agreements with countries that do not have a deal with the EU. It has begun some preparatory work on this, including launching public consultations on future free trade agreements with the United States, Canada and New Zealand.

The prospect of a trade agreement with the US in particular has raised concerns about what impact future trade terms might have on the NHS. During his state visit to the UK at the beginning of June, President Trump said the NHS would be “on the table” in trade talks. He later appeared to backtrack, explaining that although “everything’s up for negotiation”, the NHS was not something he would “consider being part of trade”. The Government has consistently said that the NHS is not up for sale. It maintains that a trade deal would not force the Government to privatise any public service or remove the ability of the UK and devolved governments to decide how to run publicly funded health services.

Private companies can already bid for contracts to provide services in the NHS in England, and some US-owned companies have won such contracts. Some campaigners fear that the terms of a trade deal with the US would allow investors to claim compensation if they lost access to the NHS market, and that this would prevent any policy changes in future to reduce the current level of privatisation within the NHS. Similar concerns arose during the failed Transatlantic Trade and Investment Partnership (TTIP) talks between the EU and the US. There have been calls, for example from the British Medical Association, for the Government to specifically exclude the NHS from future trade deals and from investor protection mechanisms.

Drug pricing is another issue that could arise during trade talks with the US. Donald Trump has blamed countries with socialised healthcare systems for negotiating “unreasonably low” prices from US drug makers, which he argues pushes up the price of prescription drugs for American patients. US negotiating objectives for a future trade deal with the UK, published in February 2019, said the US would seek to ensure transparent government reimbursement regimes for pharmaceuticals that would provide full market access for US products. The price the NHS pays for branded medicines is controlled through voluntary and statutory schemes. These arrangements limit how much the amount that the NHS spends on branded medicines can rise year-on-year.


Documents to download

Related posts

  • US tariffs: Background, perspectives and impact on the UK

    The US has announced significant increases in tariffs on imports, although has delayed full implementation. Many economists view tariffs unfavourably, arguing that they raise prices, reduce competition and risk retaliation. But others suggest that tariffs may benefit the country that applies them. UK exports to the US face an additional 10% tariff. This could be negative for UK exports and the economy. But there could be some upsides for the UK if the US goes ahead with higher “reciprocal” tariffs on many of the UK’s competitors.

    US tariffs: Background, perspectives and impact on the UK
  • Tobacco and Vapes Bill: HL Bill 89 of 2024–25

    The bill aims to create a 'smoke-free generation' by banning tobacco sales to anyone born on or after 1 January 2009, alongside other measures to tackle smoking and tobacco harms. It would also further regulate vaping, curbing its appeal to children, while enabling adult smokers to use vapes as a quitting tool. The bill is similar to the Tobacco and Vapes Bill which fell at dissolution 2024.

    Tobacco and Vapes Bill: HL Bill 89 of 2024–25
  • The future of news: Report by the House of Lords Communications and Digital Committee

    In November 2024, the House of Lords Communications and Digital Committee published a report examining the future of the news sector in the UK. While acknowledging the sector’s strengths, it expressed concerns about declining trust and revenue, threats to investigative reporting and the influence of artificial intelligence (AI). It made several recommendations to the government and others, including dedicating resources to address the challenges of AI and developing a media literacy strategy.

    The future of news: Report by the House of Lords Communications and Digital Committee